{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:44:33Z","timestamp":1791319473260,"version":"4.3.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nrgastro.2015.155","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T10:24:24Z","timestamp":1441707864000},"page":"572-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Mechanisms and management of refractory coeliac disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Tom","family":"van Gils","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petula","family":"Nijeboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy L.","family":"van Wanrooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J. J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,8]]},"reference":[{"key":"BFnrgastro2015155_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/gastro\/gou065","volume":"3","author":"NE Castillo","year":"2014","unstructured":"Castillo, N. E., Theethira, T. G. & Leffler, D. A. The present and the future in the diagnosis and management of celiac disease. Gastroenterol. Rep. (Oxf.) 3, 3\u201311 (2014).","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"key":"BFnrgastro2015155_CR2","first-page":"57","volume":"16","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma, A., Verbeek, W. H. & Mulder, C. J. Update on the management of refractory coeliac disease. J. Gastrointest. Liver Dis. 16, 57\u201363 (2007).","journal-title":"J. Gastrointest. Liver Dis."},{"key":"BFnrgastro2015155_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1309\/EVXT-851X-WHLC-RLX9","volume":"118","author":"PJ Wahab","year":"2002","unstructured":"Wahab, P. J., Meijer, J. W. & Mulder, C. J. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am. J. Clin. Pathol. 118, 459\u2013463 (2002).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrgastro2015155_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1365-2036.2009.03992.x","volume":"29","author":"A Lanzini","year":"2009","unstructured":"Lanzini, A. et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment. Pharmacol. Ther. 29, 1299\u20131308 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015155_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1365-2036.2007.03311.x","volume":"25","author":"K Kaukinen","year":"2007","unstructured":"Kaukinen, K. et al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment. Pharmacol. Ther. 25, 1237\u20131245 (2007).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015155_CR6","unstructured":"United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam. Eur. J. Gastroenterol. Hepatol. 13, 1123\u20131128 (2001)."},{"key":"BFnrgastro2015155_CR7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gut.2006.114512","volume":"56","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma, A., Verbeek, W. H., Hadithi, M, von Blomberg, B. M. & Mulder, C. J. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56, 1373\u20131378 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2015155_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","volume":"136","author":"A Rubio-Tapia","year":"2009","unstructured":"Rubio-Tapia, A. et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136, 99\u2013107 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut, G. et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136, 81\u201390 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.gastro.2008.11.026","volume":"136","author":"J West","year":"2009","unstructured":"West, J. Celiac disease and its complications: a time traveller's perspective. Gastroenterology 136, 32\u201334 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ajg.2011.104","volume":"106","author":"B Roshan","year":"2011","unstructured":"Roshan, B. et al. The incidence and clinical spectrum of refractory celiac disease in a North American referral center. Am. J. Gastroenterol. 106, 923\u2013928 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1572-0241.2007.01471.x","volume":"103","author":"VM Wolters","year":"2008","unstructured":"Wolters, V. M. & Wijmenga, C. Genetic background of celiac disease and its clinical implications. Am. J. Gastroenterol. 103, 190\u2013195 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","volume":"4","author":"A Al-Toma","year":"2006","unstructured":"Al-Toma, A. et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin. Gastroenterol. Hepatol. 4, 315\u2013319 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015155_CR14","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","volume":"119","author":"SA Di","year":"2012","unstructured":"Di, S. A., Biagi, F., Gobbi, P. G. & Corazza, G. R. How I treat enteropathy-associated T-cell lymphoma. Blood 119, 2458\u20132468 (2012).","journal-title":"Blood"},{"key":"BFnrgastro2015155_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrgastro.2010.23","volume":"7","author":"GJ Tack","year":"2010","unstructured":"Tack, G. J., Verbeek, W. H., Schreurs, M. W. & Mulder, C. J. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat. Rev. Gastroenterol. Hepatol. 7, 204\u2013213 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015155_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","volume":"34","author":"G Malamut","year":"2012","unstructured":"Malamut, G., Meresse, B., Cellier, C. & Cerf-Bensussan, N. Refractory celiac disease: from bench to bedside. Semin. Immunopathol. 34, 601\u2013613 (2012).","journal-title":"Semin. Immunopathol."},{"key":"BFnrgastro2015155_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","volume":"126","author":"WH Verbeek","year":"2008","unstructured":"Verbeek, W. H. et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin. Immunol. 126, 48\u201356 (2008).","journal-title":"Clin. Immunol."},{"key":"BFnrgastro2015155_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1471-230X-12-159","volume":"12","author":"GJ Tack","year":"2012","unstructured":"Tack, G. J. et al. Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing\u2014a cohort study. BMC Gastroenterol. 12, 159 (2012).","journal-title":"BMC Gastroenterol."},{"key":"BFnrgastro2015155_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","volume":"114","author":"C Cellier","year":"1998","unstructured":"Cellier, C. et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114, 471\u2013481 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gutjnl-2012-302265","volume":"62","author":"F Schmitz","year":"2013","unstructured":"Schmitz, F. et al. Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II. Gut 62, 509\u2013519 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2015155_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","volume":"125","author":"JJ Mention","year":"2003","unstructured":"Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730\u2013745 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR22","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.4049\/jimmunol.1103609","volume":"188","author":"SL Colpitts","year":"2012","unstructured":"Colpitts, S. L. et al. Cutting edge: the role of IFN-alpha receptor and MyD88 signaling in induction of IL-15 expression in vivo. J. Immunol. 188, 2483\u20132487 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro2015155_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/gut.2009.195131","volume":"59","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia, A. & Murray, J. A. Classification and management of refractory coeliac disease. Gut 59, 547\u2013557 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2015155_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000103891","volume":"25","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma, A., Verbeek, W. H. & Mulder, C. J. The management of complicated celiac disease. Dig. Dis. 25, 230\u2013236 (2007).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2015155_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","volume":"19","author":"S Daum","year":"2005","unstructured":"Daum, S., Cellier, C. & Mulder, C. J. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19, 413\u2013424 (2005).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrgastro2015155_CR26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7326\/0003-4819-147-5-200709040-00003","volume":"147","author":"M Hadithi","year":"2007","unstructured":"Hadithi M et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann. Intern. Med. 147, 294\u2013302 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2015155_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1572-0241.2003.07284.x","volume":"98","author":"K Vahedi","year":"2003","unstructured":"Vahedi, K. et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am. J. Gastroenterol. 98, 1079\u20131087 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR28","doi-asserted-by":"crossref","unstructured":"[No authors listed]. Giardia lamblia and coeliac disease. Lancet 302, 138 (1973).","DOI":"10.1016\/S0140-6736(73)93075-4"},{"key":"BFnrgastro2015155_CR29","first-page":"32","volume":"2000","author":"CJ Mulder","year":"2000","unstructured":"Mulder, C. J., Wahab, P. J., Moshaver, B. & Meijer, J. W. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. Scand. J. Gastroenterol. Suppl. 2000, 32\u201337 (2000).","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"BFnrgastro2015155_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1586\/eci.13.30","volume":"9","author":"H Abolhassani","year":"2013","unstructured":"Abolhassani, H. et al. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev. Clin. Immunol. 9, 561\u2013574 (2013).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrgastro2015155_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cgh.2009.12.023","volume":"8","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia, A., Talley, N. J., Gurudu, S. R., Wu, T. T. & Murray, J. A. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin. Gastroenterol. Hepatol. 8, 344\u2013349 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015155_CR32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/2010-0295-CR.1","volume":"134","author":"P Gopal","year":"2010","unstructured":"Gopal, P. & McKenna, B. J. The collagenous gastroenteritides: similarities and differences. Arch. Pathol. Lab. Med. 134, 1485\u20131489 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrgastro2015155_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11894-012-0276-2","volume":"14","author":"NM Gentile","year":"2012","unstructured":"Gentile, N. M., Murray, J. A. & Pardi, D. S. Autoimmune enteropathy: a review and update of clinical management. Curr. Gastroenterol. Rep. 14, 380\u2013385 (2012).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"BFnrgastro2015155_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/PAS.0000000000000317","volume":"38","author":"R Masia","year":"2014","unstructured":"Masia, R., Peyton, S., Lauwers, G. Y. & Brown, I. Gastrointestinal biopsy findings of autoimmune enteropathy: a review of 25 cases. Am. J. Surg. Pathol. 38, 1319\u20131329 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrgastro2015155_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12664-014-0506-7","volume":"33","author":"N Bhat","year":"2014","unstructured":"Bhat, N., Anupama, N. K., Yelsangikar, A. & Vizhi, K. Olmesartan-related sprue-like enteropathy. Indian J. Gastroenterol. 33, 564\u2013567 (2014).","journal-title":"Indian J. Gastroenterol."},{"key":"BFnrgastro2015155_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/imj.12635","volume":"45","author":"N Heerasing","year":"2015","unstructured":"Heerasing, N., Hair, C. & Wallace, S. Olmesartan-induced enteropathy. Intern. Med. J. 45, 117\u2013118 (2015).","journal-title":"Intern. Med. J."},{"key":"BFnrgastro2015155_CR37","first-page":"A7370","volume":"158","author":"YH van Beurden","year":"2014","unstructured":"van Beurden, Y. H., Nijeboer, P., Janssen, J., Verbeek, W. H. & Mulder, C. J. Diarrhoea and malabsorption due to olmesartan use [Dutch]. Ned. Tijdschr. Geneeskd. 158, A7370 (2014).","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"BFnrgastro2015155_CR38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1080\/00365520802240222","volume":"43","author":"WH Verbeek","year":"2008","unstructured":"Verbeek, W. H. et al. Incidence of enteropathy\u2014associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scand. J. Gastroenterol. 43, 1322\u20131328 (2008).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MCG.0b013e31826bea12","volume":"47","author":"SJ Van Weyenberg","year":"2012","unstructured":"Van Weyenberg, S. J., Smits, F., Jacobs, M. A., Van Turenhout, S. T. & Mulder, C. J. Video capsule endoscopy in patients with nonresponsive celiac disease. J. Clin. Gastroenterol. 47, 393\u2013399 (2012).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2015155_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1572-0241.2007.01122.x","volume":"102","author":"M Hadithi","year":"2007","unstructured":"Hadithi, M. et al. The value of double-balloon enteroscopy in patients with refractory celiac disease. Am. J. Gastroenterol. 102, 987\u2013996 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR41","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3748\/wjg.v13.i11.1696","volume":"13","author":"M Mallant","year":"2007","unstructured":"Mallant, M. et al. Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J. Gastroenterol. 13, 1696\u20131700 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2015155_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.gie.2009.10.029","volume":"71","author":"SJ Van Weyenberg","year":"2010","unstructured":"Van Weyenberg, S. J. et al. Double-balloon endoscopy as the primary method for small-bowel video capsule endoscope retrieval. Gastrointest. Endosc. 71, 535\u2013541 (2010).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2015155_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00261-012-9892-4","volume":"38","author":"SJ Van Weyenberg","year":"2013","unstructured":"Van Weyenberg, S. J. et al. Comparison of MR enteroclysis with video capsule endoscopy in the investigation of small-intestinal disease. Abdom. Imaging 38, 42\u201351 (2013).","journal-title":"Abdom. Imaging"},{"key":"BFnrgastro2015155_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1055\/s-2007-966239","volume":"39","author":"S Daum","year":"2007","unstructured":"Daum, S. et al. Capsule endoscopy in refractory celiac disease. Endoscopy 39, 455\u2013458 (2007).","journal-title":"Endoscopy"},{"key":"BFnrgastro2015155_CR45","first-page":"1622","volume":"47","author":"M Hadithi","year":"2006","unstructured":"Hadithi, M. et al. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J. Nucl. Med. 47, 1622\u201316227 (2006).","journal-title":"J. Nucl. Med."},{"key":"BFnrgastro2015155_CR46","doi-asserted-by":"publisher","first-page":"518483","DOI":"10.1155\/2013\/518483","volume":"2013","author":"P Nijeboer","year":"2013","unstructured":"Nijeboer P, van Wanrooij, R. L., Tack, G. J., Mulder, C. J. & Bouma, G. Update on the diagnosis and management of refractory coeliac disease. Gastroenterol. Res. Pract. 2013, 518483 (2013).","journal-title":"Gastroenterol. Res. Pract."},{"key":"BFnrgastro2015155_CR47","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1136\/gut.2010.223438","volume":"59","author":"RL van Wanrooij","year":"2010","unstructured":"van Wanrooij, R. L. et al. Accurate classification of RCD requires flow cytometry. Gut 59, 1732 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2015155_CR48","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","volume":"34","author":"RL van Wanrooij","year":"2014","unstructured":"van Wanrooij, R. L. et al. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J. Clin. Immunol. 34, 828\u2013835 (2014).","journal-title":"J. Clin. Immunol."},{"key":"BFnrgastro2015155_CR49","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1111\/j.1572-0241.2007.01380.x","volume":"102","author":"P Brar","year":"2007","unstructured":"Brar, P., Lee, S., Lewis, S., Egbuna, I., Bhagat, G. & Green, P. H. Budesonide in the treatment of refractory celiac disease. Am. J. Gastroenterol. 102, 2265\u20132269 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2015155_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/MCG.0b013e3181f42401","volume":"45","author":"S Jamma","year":"2011","unstructured":"Jamma, S. et al. Small intestinal release mesalamine for the treatment of refractory celiac disease type I. J. Clin. Gastroenterol. 45, 30\u201333 (2011).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2015155_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","volume":"18","author":"MS Goerres","year":"2003","unstructured":"Goerres, M. S. et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol. Ther. 18, 487\u2013494 (2003).","journal-title":"Aliment Pharmacol. Ther."},{"key":"BFnrgastro2015155_CR52","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1053\/gast.2002.31874","volume":"122","author":"HR Gillett","year":"2002","unstructured":"Gillett, H. R. et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122, 800\u2013805 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.dld.2006.10.017","volume":"40","author":"G Costantino","year":"2008","unstructured":"Costantino, G. et al. Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig. Liver Dis. 40, 74\u201377 (2008).","journal-title":"Dig. Liver Dis."},{"key":"BFnrgastro2015155_CR54","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2012.05154.x","volume":"36","author":"GJ Tack","year":"2012","unstructured":"Tack, G. J., van Asseldonk, D. P., van Wanrooij, R. L., van Bodegraven, A. A. & Mulder, C. J. Tioguanine in the treatment of refractory coeliac disease\u2014a single centre experience. Aliment. Pharmacol. Ther. 36, 274\u2013281 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015155_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut, G. et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136, 81\u201390 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015155_CR56","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","volume":"4","author":"A Al-Toma","year":"2006","unstructured":"Al-Toma, A. et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin. Gastroenterol. Hepatol. 4, 1322\u20131327 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015155_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/157488706775246102","volume":"1","author":"T Robak","year":"2006","unstructured":"Robak, T., Wierzbowska, A. & Robak, E. Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders. Rev. Recent Clin. Trials 1, 15\u201334 (2006).","journal-title":"Rev. Recent Clin. Trials"},{"key":"BFnrgastro2015155_CR58","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","volume":"4","author":"A Al-Toma","year":"2006","unstructured":"Al-Toma, A. et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin. Gastroenterol. Hepatol. 4, 1322\u20131327 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015155_CR59","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","volume":"17","author":"GJ Tack","year":"2011","unstructured":"Tack, G. J. et al. Evaluation of Cladribine treatment in refractory celiac disease type II. World J. Gastroenterol. 17, 506\u2013513 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2015155_CR60","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.3748\/wjg.v20.i46.17368","volume":"20","author":"A Al-Toma","year":"2014","unstructured":"Al-Toma, A., Nijeboer, P., Bouma, G., Visser, O. & Mulder, C. J. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J. Gastroenterol. 20, 17368\u201317375 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2015155_CR61","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","volume":"109","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma, A. et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 109, 2243\u20132249 (2007).","journal-title":"Blood"},{"key":"BFnrgastro2015155_CR62","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2010.199","volume":"46","author":"GJ Tack","year":"2011","unstructured":"Tack, G. J. et al. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant 46, 840\u2013846 (2011).","journal-title":"Bone Marrow Transplant"},{"key":"BFnrgastro2015155_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2000.00718.x","volume":"14","author":"PJ Wahab","year":"2000","unstructured":"Wahab, P. J., Crusius, J. B., Meijer, J. W., Uil, J. J. & Mulder, C. J. Cyclosporin in the treatment of adults with refractory coeliac disease\u2014an open pilot study. Aliment. Pharmacol. Ther. 14, 767\u2013774 (2000).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2015155_CR64","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gut.2006.114512","volume":"56","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma, A., Verbeek, W. H., Hadithi M, von Blomberg, B. M. & Mulder, C. J. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56, 1373\u20131378 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2015155_CR65","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","volume":"18","author":"J Gale","year":"2000","unstructured":"Gale, J., Simmonds, P. D., Mead, G. M., Sweetenham, J. W. & Wright, D. H. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J. Clin. Oncol. 18, 795\u2013803 (2000).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2015155_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bpg.2009.11.002","volume":"24","author":"JM van de Water","year":"2010","unstructured":"van de Water, J. M. et al. Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract. Res. Clin. Gastroenterol. 24, 43\u201356 (2010).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrgastro2015155_CR67","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000381076","volume":"33","author":"P Nijeboer","year":"2015","unstructured":"Nijeboer, P. et al. Therapy in RCDII: Rationale for Combination Strategies? Dig. Dis. 33, 227\u2013230 (2015).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2015155_CR68","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1172\/JCI41344","volume":"120","author":"G Malamut","year":"2010","unstructured":"Malamut, G. et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J. Clin. Invest. 120, 2131\u20132143 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2015155_CR69","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/art.37816","volume":"65","author":"HD van der","year":"2013","unstructured":"van der, H. D. et al. Tofacitinib (CP-690550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis Rheum. 65, 559\u2013570 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2015155_CR70","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJMoa1112072","volume":"367","author":"RF van Vollenhoven","year":"2012","unstructured":"van Vollenhoven, R. F. et al. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N. Engl. J. Med. 367, 508\u2013519 (2012).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:52:44Z","timestamp":1684468364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,8]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnrgastro2015155"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.155","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,8]]},"assertion":[{"value":"8 September 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2015","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article originally published online, HLA-DQ2 and fludarabine were misspelled in Figure 1. These errors have been corrected for the PDF, HTML and print versions of the article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}